EditCo Bio
PrivateLast Round
VC Round
Mar 27, 2024
Company Overview
EditCo Bio is a biotechnology company that provides CRISPR-engineered cell models and high-throughput gene editing solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EditCo Bio Comparables
Compare EditCo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SIRION Biotech | 79% | |
| Synthego | 77% | |
| Applied StemCell, Inc. | 76% | |
EditCo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 27, 2024 |
Key People
Founding team and executive leadership
EditCo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Telegraph Hill Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 119% MoM, reaching 19.3K.
- Nov 27, 2024
Grew 16% QoQ, from 79 to 92 employees.
EditCo Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EditCo Bio's valuation, stock price, and market status.